Selective inhibition by dactinomycin of NANC sensory bronchoconstriction and [125I] NKA binding due to NK‐2 receptor antagonism
- 1 March 1992
- journal article
- Published by Wiley in Acta Physiologica Scandinavica
- Vol. 144 (3), 221-231
- https://doi.org/10.1111/j.1748-1716.1992.tb09290.x
Abstract
In the present study, dactinomycin (10(-5) M) inhibited the non-adrenergic, non-cholinergic bronchoconstriction upon antidromic vagal nerve stimulation (1 Hz for 1 min) in the isolated perfused guinea-pig lung by 84%. The release of calcitonin gene-related peptide was unchanged, however, suggesting a postjunctional action. Dactinomycin (10(-5), 5 x 10(-5) M) also reduced non-adrenergic non-cholinergic bronchial contractions (maximally by 75%) induced by electrical field stimulation or capsaicin, while the cholinergic component and non-adrenergic non-cholinergic relaxation remained intact. The neurokinin-2 receptor antagonist L-659,877 (10(-6) M) had a similar effect as dactinomycin, inhibiting the non-adrenergic non-cholinergic bronchial contractions by 69%, while the neurokinin-1 receptor antagonist CP-96,345 (10(-6) M) had no effect. The bronchoconstriction evoked by neurokinin A, the selective neurokinin-2 receptor agonist Nle10neurokinin A (4-10) and capsaicin was markedly inhibited by dactinomycin while the contraction induced by substance P (SP), the selective neurokinin-1 receptor agonist Sar9Met(O2)11SP, endothelin-1 and acetylcholine was not affected. In autoradiographic experiments on guinea-pig lung, [125I]neurokinin A-labelled sections showed dense binding in the bronchial smooth muscle layer. Dactinomycin inhibited the specific binding of [125I]neurokinin A in a concentration-dependent manner (IC50 = 6.3 x 10(-6) M) and 66% of [125I]neurokinin A total binding was inhibited by 10(-4) M dactinomycin. In the rat colon, [125I]neurokinin A binding to neurokinin-2 sites on circular smooth muscle was inhibited by dactinomycin with an IC50 value of 7.9 x 10(-6) M. Dactinomycin failed to reduce increased nerve-evoked contractions or those caused by Nle10neurokinin A (4-10) per se in the rat vas deferens, which are considered to be mediated by neurokinin-2 receptor activation. In the rat portal vein, dactinomycin did not influence the contractions caused by the neurokinin-3 selective agonist Pro7neurokinin B. In conclusion, dactinomycin selectively inhibited neurokinin-2 receptor activation in guinea-pig lung and rat colon, but not in rat vas deferens, which may depend on the existence of different neurokinin-2 receptor subtypes. Neurokinin A is most likely the main endogenous excitatory non-adrenergic non-cholinergic transmitter in guinea-pig bronchi.Keywords
This publication has 32 references indexed in Scilit:
- Tachykinins and their receptors: Pharmacology, biochemistry and molecular biology advance a neuropeptide story to the forefront of scienceNeurochemistry International, 1991
- Selectivity of ruthenium red in inhibiting bronchoconstriction and CGRP release induced by afferent C‐fibre activation in the guinea‐pig lungActa Physiologica Scandinavica, 1991
- A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) ReceptorScience, 1991
- Dactinomycin inhibits non-cholinergic bronchoconstriction by capsaicin-sensitive sensory nerves in the guinea-pig by antagonizing neurokinin 2 receptor activationActa Physiologica Scandinavica, 1991
- Selective agonists of tachykinin binding sitesFundamental & Clinical Pharmacology, 1990
- New selective agonists for neurokinin receptors: pharmacological tools for receptor characterizationTrends in Pharmacological Sciences, 1988
- Characterization of neurokinin receptors in various isolated organs by the use of selective agonistsLife Sciences, 1987
- Isolation and characterization of neurokinin A, neurokinin A(3–10) and neurokinin A(4–10) from a neutral water extract of a metastatic ileal carcinoid tumourEuropean Journal of Biochemistry, 1987
- Occurrence and effects of multiple tachykinins; Sustance P, neurokinin A and neuropeptide K in human lower airwaysLife Sciences, 1987